Bio-View Ltd (TASE: BIOV)
Health Care · Health Care Equipment & Supplies · IL
₪0.84
-2.57% today · -64.5% 1Y
Bio-View Ltd (TASE: BIOV) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $3.73M and employs 31 people.
Over the last twelve months the share price has lost 64.5%, trading between 0.83 and 2.94.
Tweenvest scores Bio-View Ltd across four factors: quality 60/100, value 74/100, growth 0/100. Its strongest factor is value.
BIOV price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $3.73M
- Revenue (TTM)
- $6.25M
- P/E
- —
- EPS
- -1.13
- Dividend yield
- —
- Beta (5Y)
- -0.01
- 52-week high
- ₪2.94
- 52-week low
- ₪0.83
- Avg volume (3M)
- —
- Shares outstanding
- 13.40M
- Employees
- 31
- Next earnings
- —
About Bio-View Ltd
Bio-View Ltd, founded in 2000 and headquartered in Rehovot, Israel, is a developer, manufacturer, and global distributor of advanced automated cell imaging and analysis systems. These sophisticated solutions are utilized by clinical and research laboratories worldwide, specifically in the fields of cytology, cytogenetics, and pathology. The company's extensive product lineup includes: Accord: A semi-automated fluorescent imaging and analysis workbench microscope station. Accord Plus: An automatic fluorescent imaging system capable of real-time scanning, analysis, and sorting of diverse FISH (Fluorescence In Situ Hybridization) samples. Allegro Plus: Another automatic fluorescent imaging system engineered to pinpoint various chromosomal aberrations under fluorescent light, such as amplifications, translocations, inversions, and deletions. DUET-3: An imaging and analysis platform featuring an automated barcode reader, which streamlines the processing of multiple test types within a single scan batch. DeNovo: An automated scanning system dedicated to the precise detection, analysis, and characterization of circulating tumor cells found in peripheral blood. Solo Workstation & Solo Touch Workstation: These are offline and standalone workstations, respectively, providing advanced tools for reviewing and analyzing test results remotely from the microscope. SoloWeb: A comprehensive web-based solution that enables remote analysis, reporting, and expert consultation on cases scanned using Bio-View's systems. Furthermore, Bio-View Ltd has established a strategic partnership with ANGLE plc to jointly develop a liquid biopsy circulating tumor cell HER2 assay, specifically targeting breast cancer.
- ISIN
- IL0010960495
- Founded
- 1998
- Listed since
- Mar 12, 2006
- Exchange
- The Tel-Aviv Stock Exchange
- Currency
- ILS
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Abbott LaboratoriesNYSE: ABT | $201.83B | $116.85 | +0.18% |
| Intuitive Surgical, Inc.NasdaqGS: ISRG | $133.83B | $380.60 | +0.47% |
| Stryker CorporationNYSE: SYK | $126.37B | $332.00 | +0.77% |
| Medtronic plcNYSE: MDT | $119.49B | $93.79 | +0.47% |
| EssilorLuxottica Société anonymeENXTPA: EL | $87.56B | €162.35 | -0.52% |
| Boston Scientific CorporationNYSE: BSX | $73.00B | $50.74 | +0.73% |
| HOYA CorporationTSE: 7741 | $52.38B | ¥24,895.00 | -1.37% |
| Becton, Dickinson and CompanyNYSE: BDX | $52.30B | $192.00 | +2.33% |
Figures last refreshed Aug 18, 2026.